Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S5W-14018 · Session 5

What processes are in place to ensure that developments on new uses for off-patent drugs inform NHS prescribing guidance.

Answered Asked by Alex Cole-Hamilton LD Lodged 23 Jan 2018

The question

To ask the Scottish Government what processes are in place to ensure that developments on new uses for off-patent drugs inform NHS prescribing guidance.

The answer

Answered by Shona Robison on 30 Jan 2018 · 7 days after it was lodged, on time

There are currently local processes in existence in NHS Boards to facilitate access to off-patent drugs. A Short Life Working Group was established in 2017 to look at off label cancer medicines. The work of this group supports one of the key ambitions of our national cancer strategy, that is, to maximise the opportunities of increasing access to off patent drugs. One of the aims of the Group is to produce guidance on a national approach to the prescribing of these medicines to ensure consistency across Scotland.

In the Official Report

No contribution in the Official Report cites S5W-14018 by reference.